A Phase 3, Randomized Study of SU011248 versus Interferon-a as First-Line Systemic Therapy for Patients with Metastatic Renal Cell Carcinoma

Update Il y a 4 ans
Reference: EUCTR2004-001149-14

Woman and Man

  • | Country :
  • -
  • | organs :
  • -
  • | Specialty :
  • -

Extract

To compare the time to tumor progression (TTP) associated with SU011248 versus that associated with IFN-a for the first-line treatment of patients with metastatic renal cell carcinoma


Inclusion criteria

  • Histologically confirmed renal cell carcinoma with metastases with a component of clear (conventional) cell histology